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Abstract:  The underlying reasons for the increasing occurrence of male reproductive 
diseases (MRD) such as hypospadias, cryptorchidism, and testicular cancer (TC) over the 
last decades are still unknown. It has been hypothesized that the risk of MRD is determined 
in utero and that pregnancy dietary intake could also affect MRD risk in the offspring. 
Various studies in animals reported that cocoa and theobromine, the main stimulant of 
cocoa, exert toxic effects on the testis, inducing testicular atrophy and impaired sperm 
quality. A correlation analysis was conducted to examine the possible role of cocoa 
consumption on the occurrence of selected MRD during the prenatal and early life period of 
cases. The incidence rates between 1998-2002 of TC in 18 countries obtained from Cancer 
Incidence in Five Continents were correlated with the average per-capita consumption of 
cocoa (kg/capita/year) (FAOSTAT-Database) in these countries from 1965 to 1980, i.e. the 
period corresponding to the early life of TC cases. In order to test the above correlation in 
the case of hypospadias, the mean prevalence at birth in 20 countries (1999-2003) with 
average per-capita consumption of cocoa in these countries in the same period 
corresponding to pregnancy were used. The consumption of cocoa in the period 1965–80, 
was most closely correlated with the incidence of TC in young adults (r=0.859; p<0.001). 
An analogous significant correlation was also observed between early cocoa consumption 
and the prevalence rates of hypospadias in the period 1999-2003 (r=0.760; p<0.001). 
Although the ecological approach used in this study cannot provide an answer on the causal 
relationship between consumption of cocoa in early life and TC and hypospadias, the results 
are suggestive and indicate the need of further analytic studies to investigate the role of 
individual exposure to cocoa, particularly during the prenatal and in early life of the 
patients.  
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1. Introduction  
Male reproductive tract diseases (MRD) such as hypospadias, cryptorchidism, and testicular cancer 
(TC) have been increasing for at least 40 years in the developed countries. In particular, TC is 
currently the most diagnosed malignancy in men aged 20-34 years and its incidence in some countries 
has risen 3-fold over the last decades [1-3]. These male developmental disorders have been proposed 
to comprise a common underlying syndrome with a common aetiology resulting from the disruption of 
embryonic programming and gonadal development during fetal life, termed Testicular Dysgenesis 
Syndrome (TDS) [4]. A hormonal etiology most likely underlies this syndrome, although it is believed 
to have more than one cause, possibly including nutrition and high calorie intake during early life [4-
6]. 
The pathogenetic role of nutrition originated from several epidemiological observations of 
constantly increasing incidence of TC since the beginning of the 20th century with the only major 
interruption in this trend occurring for men born during World War II or immediately thereafter, when 
the daily energy intake had been dramatically reduced [6]; moreover, it has been proven that poor and 
nutritionally underprivileged populations such as African, including U.S. blacks, and Asian 
populations experience a lower risk of MRD than more affluent people [6]. 
The increasing occurrence of MRD over time in developed countries might be consistent with 
increases in the consumption of some sweet foods, such as cocoa. The per-capita intakes of cocoa, in 
fact, have been increasing since at least 1961 year in most developed countries [8]. For example, in 
Denmark cocoa consumption more than doubled in the period 1961-2004. Similar trends have been 
observed in other European countries [8,9]. 
In addition, several studies have reported that cocoa and its main stimulant theobromine exert toxic 
effects on the testis, inducing testicular atrophy accompanied by aspermatogenesis or oligo-
spermatogenesis and that even low doses of cocoa impair sperm quality [10-13]. 
In human cells in vitro, theobromine induced sister chromatid exchange and chromosomal breaks. 
In cultured mammalian cells, it induced gene mutations and sister chromatid exchange [41]. 
Theobromine was also found to produce a higher and more linear rate of sister chromatid exchange 
damage than caffeine [10,14]. In addition, progeny from the mice fed chocolate at doses similar to 
those consumed by “high” consumption human populations, presented considerable morphometric 
abnormalities in the kidney structure, with the lower number of glomeruli per mm
2 and their increased 
diameter [15].  
As dietary patterns of cocoa consumption are extremely difficult to investigate retrospectively in 
humans, a correlation analysis was conducted to examine the possible role of cocoa consumption on 
the occurrence of selected male reproductive disorders during the prenatal and early life period of 
cases.  
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2. Methods 
The incidence rates of TC between 1998–2002 in 18 countries (Denmark, Finland, Norway, 
Sweden, U.K., Italy, Spain, France, Switzerland, Germany, Poland, Netherland, USA, China, India, 
Australia, Canada, Japan) obtained from Cancer Incidence in Five Continents (Source: International 
Agency for Research on Cancer - IARC) were correlated with the average per-capita consumption of 
cocoa (Source: Food and Agriculture Organization - FAO) in these countries from 1965 to 1980, i.e. 
the period corresponding to the early life of TC cases [9,16]. 
In this analysis, data from 18 countries, for which both truncated age-adjusted cancer incidence 
rates for 20–34-year-olds and detailed cocoa consumption data (FAOSTAT Database) in the period 
corresponding to the gestation and infancy of the cases (1965-1980) were available, were used. 
Incidence rates for 20–34-year-olds were chosen because most cases of testicular cancer occur in this 
age group. 
Several countries reported data to the IARC from only one local cancer registry that was assumed to 
represent the incidence rate for the whole country (e.g. Canada, Denmark, Finland, The Netherlands, 
Norway and Sweden). Where multiple registries from one country were available, the average value of 
the age-adjusted incidence rates was employed as a representative rate for the country (e.g. Australia, 
China, France, Germany, India, Italy, Japan, Peru, Poland, Spain, Switzerland and UK). Since in the 
U.S. more than one cancer registry is operating, the registry for white people by the SEER program 
was chosen as a representative value for the U.S [16]. 
The cocoa consumption data (kg/capita/year) from 1965 to 80 available from the FAOSTAT 
Database were used [9].  
The International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS), a 
nongovernmental organization of the World Health Organization, collects data on selected birth 
defects from countries that have actively functioning registries. Hypospadias is included in this set of 
birth defects [17].  
In order to test the above correlation in the case of hypospadias, the mean prevalence at birth in 20 
countries (1999-2003 from ICBDMS Database) with average per-capita consumption of cocoa 
(FAOSTAT-Database) in these countries in the same period corresponding to pregnancy were used. 
Hypospadias was specifically chosen trying to avoid the risk of possible underestimation reported 
for other congenital defects of the male reproductive tract such as chryptorchidism, and because the 
available data on this condition are rather accurate [18]. 
All of the data were analyzed by SPSS-13 (SPSS Institute, Chicago). The 0.05 level of probability 
was used as the criterion for statistical significance. The Pearson product-moment correlation 
coefficients (r values) between the incidence of TC in 18 countries and the per-capita consumption of 
cocoa were examined. The same procedure was followed in the case of hypospadias. 
3. Results 
The 1998-2002 truncated age-adjusted incidence rates for testicular cancer in the 20–34 age group 
varied greatly from one country to another; Norway had the highest rate at 23.8/100,000, followed by 
Denmark (21.3), Switzerland (20.6) and Germany (17.1) (Figure 1). The lowest rate was found in India Int. J. Environ. Res. Public Health 2009, 6          
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(1.0) and China (1.6). Consumption of cocoa during the corresponding period of pregnancy or infancy 
seems to follow similar patterns to TC incidence rates of adult life. In fact, the highest consumption 
(kg/capita/year) of cocoa was registered for the Nordic countries such as Denmark (1.92), Germany 
(2.23) and Norway (1.73) together with Switzerland (1.91), while the lowest in India (0.01) and China 
(0.01).  
The correlation coefficients for the association between the incidence rate of TC and the cocoa 
intake in 18 countries confirm these preliminary observations. The consumption of cocoa in the period 
1965–80, was most closely correlated with the incidence of TC in young adults (r=0.859; p<0.001). An 
analogous significant correlation was also observed between early cocoa consumption and the 
prevalence rates of hypospadias in the period 1999-2003 (r=0.760; p<0.001).  
Figures 1 and 2 show the correlation between these two diseases and the consumption of cocoa in 
the early life period of the cases. 
 
Figure 1. Correlation between TC incidence rates for 20-34 years-olds (1998-2002) and 
per capita cocoa consumption (1965-1980) in 18 countries. 
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Figure 2. Correlation between prevalence rate of hypospadias (1999-2003) and per capita 
cocoa consumption in 20 countries in the same period corresponding to pregnancy. 
 
Figure 3. Trend in average per-capita consumption of cocoa (1961-2003) in nine 
European countries (Denmark, Finland, Norway, Sweden, U.K., Italy, Spain, France and 
Switzerland) 
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Analysing cocoa beans consumption trends in selected developed countries in the last 40 years, we 
observed a steady increase of 1% per year, that seems to be consistent with the parallel increases in the 
incidence of TC and other male reproductive diseases registered in the same period [3]. Figure 3 shows Int. J. Environ. Res. Public Health 2009, 6          
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a linear trend (R
2 = 0.877) in average per-capita cocoa consumption in nine European countries 
(Denmark, Finland, Norway, Sweden, U.K., Italy, Spain, France and Switzerland) from 1961 to 2003.  
An analysis was also undertaken to examine whether the correlation of TC with cocoa intake was 
stronger for the prenatal period, than for a period of time in later life, using a method developed by 
Paulozzi [19]. 
The finding was that the association between TC incidence rates (1998-2002) among men in their 
20s, 30s and 40s is stronger with cocoa consumption in their prenatal period (1965-1980) than the 
association with cocoa consumption in the 1990s (adulthood) (Table 1). This, together with the high 
correlation of cocoa consumption with hypospadias prevalence, suggests that the critical exposure 
period might be closer to birth rather than in later life.  
 
Table 1. Correlation coefficients between the incidence of TC by age group in 18 countries 
(1998-2002) and cocoa consumption in two periods: in prenatal life (1965-1980) and in 
adulthood (1990-1995). 
Age group (years) 
Years of cocoa intake 
1965-1980 1990-1995 
0-19 0.606  0.260 
20-29 0.824 0.529 
30-39 0.897 0.670 
40-49 0.912 0.725 
All ages  0.884  0.631 
 
4. Discussion 
 
This correlation analysis suggests that cocoa consumption during early life might be correlated to 
both TC incidence among young men aged 20-34 years and hypospadias, a reproductive congenital 
defects supposed to underline the same pathogenetic mechanism of TC. 
In particular, the increasing incidence of TC over time in developed countries is consistent with 
increases in the consumption of cocoa. The intake of some of the main sweet ingredients, in fact, such 
as cocoa and sweeteners increased significantly during the last 45 years in developed countries [8,9]. 
Over the years 1961–2004 cocoa consumption overall in developed countries grew at an average rate 
of 1 % per year [9]. For example, in Denmark cocoa consumption more than doubled in the period 
1961–2004. Similar trends have been observed in other European countries [8,9]. The magnitude of 
these increases is similar to those noted for incidence rates of testicular cancer and other MRD. The 
reduced risk for testicular cancer for the cohorts of Danish, Norwegian, Swedish and Japanese men 
born during World War II is also consistent with a greatly reduced supply of sweet foods and cocoa 
during the war. 
Data from food balance sheets (FAOSTAT) indicate that the consumption of cocoa in Denmark, 
where TC and hypospadias rates are elevated, is among the highest in the world and is more than three 
times that in Finland, where MRD rates are rather low [9]. 
Is there any evidence that this association may be causal?  Int. J. Environ. Res. Public Health 2009, 6          
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Cocoa powder is a complex substance containing several biologically active compounds, including 
theobromine, caffeine, serotonin, phenylethylamine and cannabinoid-like fatty acids [11]. 
Various studies reported that theobromine, the main stimulant of cocoa, exerts toxic effects on the 
testis, inducing testicular atrophy accompanied by aspermatogenesis or oligospermatogenesis and that 
even low doses of cocoa impair sperm quality [10-14]. 
Friedman et al. reported that feeding theobromine to male Osborne-Mendel rats at a dietary level of 
0.5% for 64 weeks resulted in severe testicular atrophy in 94% of animals, with aspermatogenesis in 
82% [20]. The results were confirmed in another strain of rats; following 19 weeks of feeding 
theobromine, all rats showed atrophy, and 79% had aspermatogenesis [10]. 
Tarka et al. found that feeding theobromine at levels of 0.2-1.0 % in the diet (90-140 to 500-600 
mg/kg bw per day) for a period of 28 days to rats produced severe testicular atrophy at the 0.8% level 
and seminiferous tubular-cell degenerationat the 0.6% level [13]. These authors also studied the 
potential reversibility of this phenomenon by feeding proven breeder male Sprague-Dawley Rats 0.2, 
0.6 or 0.8% theobromine (88, 244 or 334 mg/kg bw per day, respectively) for 49 days, performing 
unilateral orchiectomy at that time and allowing rats to recover on a theobromine-free diet for an 
additional 49 days. Histologically, the effects at the two highest dose levels were largely irreversible [13].  
Funabashi et al. administered orally theobromine to male Sprague-Dawley rats at dose levels of 250 
and 500 mg/kg for 2 weeks starting at the age of 6 or 8 weeks, and for 4 weeks from the age of 6 
weeks [21]. Histopathological examination of reproductive organs revealed toxic findings in the testis 
such as degeneration/necrosis and desquamation of spermatids and spermatocytes, vacuolization of 
seminiferous tubules, and multinucleated giant cell formation at 500 mg/kg after 2 weeks of dosing at 
both ages, and at 250 and 500 mg/kg after 4 weeks of dosing [21].  
There was also genetic effects of theobromine in animals. In vivo, theobromine induced sister 
chromatid exchange and micronuclei in the bone marrow of Chinese hamsters. In human cells in vitro, 
theobromine induced sister chromatid exchange and chromosomal breaks. In cultured mammalian 
cells, it induced gene mutations and sister chromatid exchange [10,14]. In particular, theobromine was 
found to produce a higher and more linear rate of sister chromatid exchange damage than caffeine 
[10,14].  In addition, progeny from the mice fed chocolate presented considerable morphometric 
abnormalities in the kidney structure, with the lower number of glomeruli per mm
2 and their increased 
diameter [15].  
These findings from animal studies can be compared with the only human study on exposure to 
theobromine during pregnancy and early childhood [22]. This study examined the level of theobromine 
in mother’s milk after ingestion of 113 g (4 ounces) milk chocolate (containing a total of 240 mg of 
theobromine). Peak theobromine concentrations of 3.7 to 8.2 mg/L were found in all fluids including 
breast milk at 2 to 3 hour after ingestion of the chocolate [22]. According to the European Food Safety 
Authority (EFSA), if this amount of chocolate were to be ingested four times a day, it would 
potentially lead to an exposure of the breast fed infant of about 10 mg theobromine/day (corresponding 
to 1-2 mg/kg b.w.) [23]. Such an exposure might result in pharmacologically active theobromine levels 
since newborn babies and infants have very low CYP1A2 activity and would metabolise theobromine 
much more slowly than adults [23]. 
An alternative explanation of the relationship between cocoa consumption and occurrence of MRD 
might be that consumption of cocoa and chocolate-containing confectionery could be related to the Int. J. Environ. Res. Public Health 2009, 6          
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hormonal equilibrium of the mother during pregnancy and of the infant in the development of MRD in 
later life. Consumption of energy-dense foods during pregnancy or childhood could negatively effect 
the balance between free and bound estrogens. The foetus could be exposed to increased estrogen 
levels through the availability of the high maternal estradiol levels occurring during pregnancy. 
Bioavailability of estradiol during pregnancy is mainly regulated by the levels of sex hormone-binding 
globulin (SHBG), whose most important endogenous suppressor is insulin [24]. It is well-established 
that sweet and cocoa consumption is associated with increased levels of insulin. In fact, though cocoa 
and chocolate-containing confectionery elicits only a low glycemic response due to its poor sugar 
content, insulin responses to chocolate is disproportionately high, being almost 50-60 % higher than its 
glucose score [25].  
Fung et al. found recently that a Western pattern, which represents a higher intakes of sweets and 
desserts, was associated with a higher level of estradiol and lower concentration of SHBG in women 
[26]. 
In particular, it was observed that pregnancy intake of sweets was significantly related to the 
reduction of serum sex hormone-binding globulin (SHBG) at the 16th gestational week [27]. The 
exposure to free estrogens during pregnancy was suggested to increase the risk of MRD in the 
offspring later in life [4,5]. 
Finally, cocoa beans are some of the principal dietary sources of ochratoxin A, a mycotoxin that 
causes adducts in testicular DNA of rats and is an established cause of liver and kidney tumors in 
rodents and is a testicular toxicant [28,29]. In addition, there is some evidence that ochratoxin might be 
a cause of TC [29]. Surprisingly, there were no previous studies on the cocoa consumption in the 
development of MRD in humans, whereas toxic effects on male reproduction in animals are 
established.  
We chose specifically hypospadias and TC trying to avoid the risk of possible underestimation 
reported for other congenital defects of the male reproductive tract, such as chryptorchidism, and 
because the available data on these conditions are rather accurate. The ecological approach used in this 
analysis has well known limitations. For example, it is not to be excluded that cocoa consumption may 
be simply a surrogate marker of affluence or other environmental factor. The data on the prevalence of 
hypospadias could be incomplete or non uniform, while the food consumption data may not apply to 
the cases under study. In fact, ecological studies correlating prevalence and/or incidence rates of a 
disease with the dietary practices in various geographical areas can only generate hypotheses for 
further studies.  
Food consumption data provided by the FAO present other types of limitations, including 
differences in classification and definition of food items, completeness, and spatial and temporal 
variability and could not be adjusted for age, gender and other possible confounding factors, such as 
alcohol intake.  
In addition, FAO consumption data may be particularly incomplete in developing countries such as 
India and China. However, we separated the analysis excluding these two countries and found the 
same results. 
These findings, therefore, suggest that the associations found may not be spurious, and might 
deserve further studies of hypospadias and TC at the individual level to investigate the role of dietary 
intake of cocoa. Int. J. Environ. Res. Public Health 2009, 6          
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5. Conclusions 
Our findings suggest that exposure to cocoa during prenatal life or childhood may be associated to 
the risk of both hypospadias and testicular cancer in the offspring. The association between MRD and 
consumption of cocoa has been discussed in relation to reproductive toxicity of cocoa theobromine. 
However, it is not to be excluded that an increase in insulin production, the inhibition of serum SHBG 
and consequent increase of free circulating oestrogen levels could have a direct role on the occurrence 
of MRD. Correlation studies on the association of diseases rates with the dietary practices in various 
geographical areas can only generate hypotheses for further studies. It is probable that the data sets 
from developing countries are less complete than those from developed countries because of problems 
with under-diagnosis. Nevertheless, the overall association is convincing, plausible and at least may 
serve to stimulate further epidemiological and experimental studies. 
At present, there are no other epidemiologic studies examining specifically the association between 
TC and hypospadias and consumption of cocoa. The evidence examined here suggests that, future 
analytic studies at the individual level of TC hypospadias and other reproductive disease of the male 
reproductive system, should investigate the role of dietary intake of cocoa and sweet foods, 
particularly during the prenatal and in early life of the patients. 
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